Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

Share Price is delayed by 15 minutes
Get Live Data
276.00    0.00 (0.00%)
Bid:
261.00
Ask:
272.00
Spread: 11.00 (4.215%)
Market Cap: £247.17m
WIL Live PriceLast checked at - London Stock Exchange

Intraday Wilmington Share Chart

Acquisition

19 Jan 2016 07:00

RNS Number : 2460M
Wilmington PLC
19 January 2016
 

 

19 January 2016

Wilmington plc

 

Acquisition of JMH Publishing Limited trading as "Wellards"

 

· Acquisition adds online education capability for the Insight knowledge area 

 

· Wellards extensive NHS knowledge base strengthens Wilmington's Healthcare offering

 

· High quality revenue streams - 70% from subscription products with over 90% renewal rates

 

Wilmington plc ("Wilmington" or "the Group"), the knowledge leader in Risk & Compliance, Finance, Legal, and Insight, announces the acquisition of JMH Publishing Ltd ("Wellards" or "the business"), a leading UK provider of specialist and accredited online education for the healthcare industry and owner of the respected trading brand "Wellards".

 

As part of Wilmington, Wellards will become the principal education and training platform for the Insight division and will benefit from Wilmington's enhanced healthcare market access, both in the UK and in mainland Europe.

 

Terms of the deal

 

Wilmington is acquiring Wellards for an initial consideration of £4.2m payable in cash. Wellards is being acquired with £1.3m of cash in its balance sheet. A final payment of up to £0.9m in March 2016 will be made once the final net current asset position has been agreed.

 

The consideration will be financed out of the Group's existing £65.0m multicurrency debt facility and is expected to be earnings enhancing in the first full year of ownership.

 

Background to Wellards

 

Wellards, established in 1990 is based in Kent, England and is managed by its founder John Heath, CEO who will remain with the business for a transitional period of one year. Wellards core online modules deliver the industry standard for effective and comprehensive NHS training and are an indispensable resource to enable understanding of the NHS and how it functions.

 

Wellards runs over 70 online courses and has more than 25,000 registered users. Subjects covered include critical areas for pharma industry representatives such as market access and financial flows, clinical modules of key therapy areas such as cancer, diabetes and cardiovascular health, ABPI code and compliance. Over 70% of its revenue is generated by its online training portal, Wellards Academy, which services the needs of UK pharmaceutical and Medtech commercial staff.

 

In the twelve month period ended 31 October 20151, revenue per the unaudited management accounts was £2.0m, an increase of 12 percent on the same period in 2014 and the adjusted profit before interest, amortisation and taxation was £0.6m1. Gross assets were 2.0m1. Wellards will provide Wilmington with an additional attractive recurring revenue stream as over 70% of its revenue is subscription based with over 90% renewal rates.

 

Acquisition rationale

 

The acquisition of Wellards is consistent with Wilmington's strategy of acquiring complementary businesses with high repeat revenues and strong, cash generative income streams in the Group's key markets. The addition of Wellards provides Wilmington with education capability for its Insight division completing the strategic objective of having information, networking and education offerings across all of Wilmington's four knowledge areas.

 

1 unaudited.

 

Commenting on the acquisition, Pedro Ros, Chief Executive Officer of Wilmington, said:

 

"I am delighted to welcome Wellards to Wilmington; its addition completes one of our strategic objectives of having information, education and networking capabilities for each of our knowledge areas. I am particularly excited by the scalability of the online products both in the broader healthcare industry and internationally where we can utilise our existing market access in particular to the French and German healthcare markets."

 

John Heath, founder and CEO of Wellards commented: 

 

"I'm delighted that Wellards is now part of Wilmington. For many years we have worked closely with Binleys; a business within Wilmington's Insight division, providing customers with the knowledge and insight needed to interpret the practical value of the Binleys resource and this acquisition is a very natural extension of our partnership.

 

I'm looking forward to developing new services which will enhance the product portfolio of both companies"

 

For further information, please contact:

Wilmington plc

Pedro Ros, Chief Executive Officer

Tony Foye, Chief Financial Officer

020 7422 6800

FTI Consulting

Charles Palmer

Emma Appleton

020 3727 1000

 

Notes to Editors

 

Wilmington plc is the recognised knowledge leader and partner of choice for information, education and networking in Risk & Compliance, Finance and Legal as well as the Insight leader in a number of chosen industries. Capitalised at approximately £225 million, Wilmington floated on the London Stock Exchange in 1995.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQFVLLFQFFBBBF
Date   Source Headline
1st Dec 20149:07 amRNSVoting Rights Announcement
20th Nov 20143:47 pmRNSShareholding Announcement
13th Nov 20143:40 pmRNSHolding(s) in Company
6th Nov 20145:11 pmRNSAGM Results 2014
6th Nov 20147:00 amRNSInterim Management Statement
3rd Nov 20141:39 pmRNSVoting Rights
27th Oct 201411:33 amRNSCorrection: Share Awards
20th Oct 20146:17 pmRNSCorrection: Share Awards
20th Oct 20145:10 pmRNSDirector/PDMR Shareholding
20th Oct 20145:09 pmRNSShare Awards
17th Oct 20143:54 pmRNSHolding(s) in Company
10th Oct 20144:16 pmRNSHolding(s) in Company
1st Oct 20141:46 pmRNSTotal Voting Rights
23rd Sep 201412:15 pmRNSShare Awards
18th Sep 20147:00 amRNSFinal Results
1st Sep 20145:16 pmRNSVoting Rights Announcement
1st Aug 20147:00 amRNSVoting Rights and Capital
14th Jul 20142:58 pmRNSHolding(s) in Company
14th Jul 20142:55 pmRNSHolding(s) in Company
1st Jul 201411:32 amRNSVoting Rights and Capital
23rd Jun 20149:00 amRNSNotice of Results
19th Jun 201411:05 amRNSHolding(s) in Company
12th Jun 20147:00 amRNSCEO Appointment
5th Jun 20145:26 pmRNSHolding(s) in Company
2nd Jun 201412:44 pmRNSTotal Voting Rights
2nd Jun 20149:00 amRNSHolding(s) in Company
22nd May 20142:22 pmRNSHolding(s) in Company
13th May 20147:00 amRNSInterim Management Statement
2nd May 20142:04 pmRNSVoting Rights & Capital
9th Apr 201412:36 pmRNSHolding(s) in Company
2nd Apr 201410:55 amRNSTotal Voting Rights
31st Mar 20144:30 pmRNSHolding(s) in Company
3rd Mar 20149:40 amRNSVoting Rights and Capital
25th Feb 20147:01 amRNSRetirement of Chief Executive
25th Feb 20147:00 amRNSInterim Results
17th Feb 20142:58 pmRNSHolding(s) in Company
4th Feb 20141:50 pmRNSVoting Rights and Capital
2nd Jan 20142:12 pmRNSVoting Rights and Capital
20th Dec 201311:32 amRNSNotice of Results
2nd Dec 20135:57 pmRNSTotal Voting Rights
19th Nov 20137:00 amRNSHolding(s) in Company
11th Nov 20134:48 pmRNSHolding(s) in Company
5th Nov 20133:39 pmRNSResult of AGM
5th Nov 20137:00 amRNSInterim Management Statement
4th Nov 201312:23 pmRNSTotal Voting Rights
24th Oct 201311:52 amRNSShare Awards
4th Oct 201311:42 amRNSHolding(s) in Company
2nd Oct 20134:31 pmRNSDirector/PDMR Shareholding
1st Oct 20134:51 pmRNSHolding(s) in Company
1st Oct 201311:33 amRNSVoting Rights and Capital

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.